TargetMol

MEN935

Product Code:
 
TAR-T24448
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24448-5mg5mg£930.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24448-50mg50mg£1,821.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24448-100mg100mg£2,319.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
MEN935 is an antihypertensive agent. It is also a β-adrenoceptor blocker.
CAS:
75708-29-1
Formula:
C25H32ClN3O4
Molecular Weight:
474
Purity:
0.98
SMILES:
O.Cl.CC(C)(CCn1c2ccccc2[nH]c1=O)NCC(O)COc1cccc2ccccc12

References

1. Arrigoni J, Lambrecht JT. [Complications during and after third molar extraction]. Schweiz Monatsschr Zahnmed. 2004;114(12):1271-86. French, German. PubMed PMID: 15646673. 2. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kes?niemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005 Jan 15;95(2):194-8. PubMed PMID: 15642551. 3. Eikelis N, Lambert G, Wiesner G, Kaye D, Schlaich M, Morris M, Hastings J, Socratous F, Esler M. Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab. 2004 May;286(5):E744-52. Epub 2004 Jan 13. PubMed PMID: 14722031. 4. Palluk R, Hoefke W, Gaida W, Mierau J, Bechtel WD. Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):277-83. PubMed PMID: 3020439.